Barts Cancer Institute (Queen Mary University of London)

YouTube video by BCIQMUL Driving discoveries for tomorrow's cancer care at Barts Cancer Institute

Today, on #WorldCancerDay, we’re taking you behind the scenes at Queen Mary's Barts Cancer Institute and introducing you to the people who are making progress possible.

Follow us to stay up to date with new developments.

🧪 #UnitedByUnique #MedSky #OncoSky @qmul.bsky.social @cancerresearchuk.org

Margaret, a participant in the study, has lived with her cancer for more than 13 years since her original diagnosis in 2012.

💬“I’m eternally grateful that Professor Kocher has given me all of these extra years to enjoy with my loved ones,” Margaret comments.

New approach offers hope for people with rare eye cancer - Barts Cancer Institute - Queen Mary University of London A more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer, according to researchers...

People with a rare eye cancer (uveal melanoma) that has spread to the liver may survive for longer when doctors take a more active approach to monitoring and treatment, according to results from Professor Hemant Kocher and team.

@qmul.bsky.social #medsky #oncosky 🧪

Transgender Awareness Week & we complete our episode with the wonderful Dr Alison Berner⭐️

🎙️ UCATS & OUTpatients
work supporting the transgender community

🎙️Don’t let fear of Saying the wrong thing stop you DOING the right things⭐️

@drallycat.bsky.social
@oncodaily.bsky.social
@qmbci.bsky.social

New spinout launches to advance early pancreatic cancer detection Queen Mary University of London has launched a new company, Procyon Diagnostics, to provide pioneering early cancer detection tests. The company’s first test, PancRISK, offers new hope for detecting p...

📰 15 years of research by Prof. Tatjana Crnogorac-Jurcevic at BCI have led to the launch of Procyon Diagnostics, a new Queen Mary Innovation #spinout company developing a simple test for early #PancreaticCancer detection.

@qmul.bsky.social | @qminnovation.bsky.social
🧪 #medsky #oncosky

Read more ⤵️

PhD Studentships Projects - CRUK RadNet Applications now open for PhD Studentships for September 2026 The CRUK City of London Radiation Research Centre PhD Programme This is a unique multidisciplinary and collaborative training opportuni...

Interested in carrying out research in cancer Radiotherapy and Radiobiology? Applications are open now for our PhD programme for 2026 intake!

@kingscollegelondon.bsky.social @qmbci.bsky.social @crick.ac.uk @ucl.ac.uk

crukradnet.colcc.ac.uk/phd-students...

The PhD will supervised by both myself and @mirazrahman.bsky.social at @qmbci.bsky.social and @kingscollegelondon.bsky.social, and is an outstanding opportunity to gain expertise in structural biology, medicinal chemistry, and cancer biology, at the cutting edge of translational oncology.

Proud to partner @cancerresearchuk.org and Windsor Fellowship to offer Black Leaders in Cancer #PhD scholarships. Check our projects and apply by Weds 5 Nov: https://www.colcc.ac.uk/black-leaders-phd-programme/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded

Check out some of the #PhD projects we have on offer, starting Sept 2026. Find out more and apply by noon, Weds 5 Nov: https://www.colcc.ac.uk/phd-studentships/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded

Our first Centre for Cancer Evolution PI retreat! A wonderful day at Goodenough House discussing science, strategy and forging new collaborations @qmbci.bsky.social

Professors x 10, Faculty of Medicine & Dentistry | Veredus QUEEN MARY UNIVERSITY OF LONDON Professors x 10, Faculty of Medicine and Dentistry London Competitive Remuneration Package Queen Mary University of London seeks up to 10 world-leading translational re...

Come and join us at the Barts Cancer Institute @qmbci.bsky.social ! Our medical school, part of Queen Mary University of London @qmulfmd.bsky.social is hiring 10 professors!! www.veredus.co.uk/job/job-747a/. Contact me for a chat if interested.

Scientific Review Paper Published in BJUI Compass, titled: Emerging tools for the early detection of prostate cancer. Written by Haider et al.

Could imaging, genetic and biomarker tests improve early #ProstateCancer detection?

A team led by Prof Prabhakar Rajan @qmbci.bsky.social explore different detection strategies in their latest publication in @bjuijournal.bsky.social.

Grab a ☕ and read: doi.org/10.1002/bco2...

New AI model sheds light on high-risk skin cancer: Q&A with the authors - Barts Cancer Institute - Queen Mary University of London Researchers at Barts Cancer Institute (BCI), Queen Mary University of London, have developed an artificial intelligence (AI) tool that could help doctors identify which skin cancers are most likely to...

📰 A new AI tool could help doctors identify which skin cancers are most likely to spread.

We spoke to Professor Alex Wang and Dr Emilia Peleva to find out more about their new study and next steps ⬇

@qmul.bsky.social | @cruk-cityoflondon.bsky.social

🧪 #medsky #oncosky #ArtificialIntelligence

🎉 Join us in congratulating four BCI researchers who have been promoted!

Promoted to Professor:
🔹Professor Angus Cameron
🔹Professor Jun Wang

Promoted to Senior Lecturer:
🔹Dr Diu Nguyen

Promoted to Reder:
🔹Dr Miguel Ganuza

@qmul.bsky.social @qmulfmd.bsky.social @cruk-cityoflondon.bsky.social

Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth - Barts Cancer Institute - Queen Mary University of London An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes – known as extrachromosomal DNA, or ecDNA – can drive the growth of a large proportion of ...

📰Rogue DNA rings could provide early clues to brain cancer’s growth, according to new results co-led by Dr @benjaminwerner.bsky.social, as part of international @cancergrand.bsky.social collaboration

@qmul.bsky.social | @crick.ac.uk | @stanford.edu | @aacrjournals.bsky.social | #medsky #oncosky 🧪

3/ The trial results showed that people given the treatment lived nearly twice as long as those given standard chemotherapy. Around 30% of people achieved a complete remission following treatment, meaning all detectable signs of the disease had disappeared.

2/ 💬Prof Powles says: "This is a landmark moment in the care of advanced bladder cancer – the first of its kind in 40 years."

Breakthrough life-extending treatment for advanced bladder cancer available on NHS - Barts Cancer Institute - Queen Mary University of London The new combination treatment offers hope to thousands of people living with advanced urothelial cancer. The clinical trials, led by Professor Tom Powles at Barts Cancer Institute, Queen Mary University of London, showed that overall survival rates were almost twice as long with this new treatment compared to the current standard treatment.

📰 NICE has approved a breakthrough life-extending combination treatment for bladder cancer for use in the NHS from today, following trials led by Prof Tom Powles at BCI @qmul.bsky.social.

🧪 #medsky #oncosky #bladdercancer
@qmulfmd.bsky.social | @cruk-cityoflondon.bsky.social

Fantastic news, congratulations to Professor
Tom Powles and team for all their work leading the clinical trials for this breakthrough treatment!

Proud to be named as a finalist in the University of the Year category in the 2025 UK Social Mobility Awards, which recognise organisations taking action to level the playing field for people from less-advantaged socio-economic backgrounds.

Roll on October 2nd when the winners will be announced!

Pancreatic Cancer Research Fund Tissue Bank achieves landmark international accreditation - Barts Cancer Institute - Queen Mary University of London The Pancreatic Cancer Research Fund Tissue Bank (PCRFTB) has become the first in England to receive ISO 20387:2018 accreditation, an international standard that recognises excellence in biobanking.

Congratulations to our team at the Pancreatic Cancer Research Fund Tissue Bank (PCRFTB), who have achieved a landmark international accreditation 🎉

They have become the first in England to receive ISO 20387:2018 accreditation, an international standard recognising excellence in biobanking. 🧪

BCI’s Prof Jane Sosabowski and Dr Jennifer Young will lead a £1m project studying radiolabelled nanomedicines. The team will track how these nanomedicines move within the body, helping to improve tumour targeting and avoid unintended accumulation and side effects.

£10m awarded to partnership investigating innovative radiolabelled nanomedicines - Barts Cancer Institute - Queen Mary University of London Researchers at Barts Cancer Institute (BCI), Queen Mary University of London, will play a part in a revolutionary new partnership with King’s College London and the University of Leeds, aiming to acce...

💡 £10 million has been awarded to a new UK-wide partnership investigating innovative healthcare nanotechnologies.

The initiative, funded by EPSRC, will unite researchers at BCI @qmul.bsky.social, @kingscollegelondon.bsky.social & @universityofleeds.bsky.social.

#medsky #oncosky 🧪

🏆The winner of our 2025 Image Competition is Dr Elly Tyler of @qmbci.bsky.social, for her image 'Where Collagen Burns and Immunity Falters'!

In this breast tumour tissue, collagen fibres in the extracellular matrix blaze like wildfire.

Aspiring scientists gain a ‘burst’ of inspiration at the BCI - Barts Cancer Institute - Queen Mary University of London Molecules exhaled in the breath may provide clues to detect blood cancer, according to new research by scientists at Barts Cancer Institute. The findings could enable the development of a blood cancer...

🌟 We recently welcomed 43 aspiring young scientists to BCI as part of two #WorkExperience programmes (STARS and BURSThrough) designed to break down perceived barriers to #HigherEducation and ignite students' aspirations to pursue careers in #STEM 🧪

@qmul.bsky.social | @cruk-cityoflondon.bsky.social

The research was published in @hemasphere-journal.bsky.social and used breathalyser technology developed by @owlstonemedical.bsky.social.

Could a breath test detect blood cancer? - Barts Cancer Institute - Queen Mary University of London Molecules exhaled in the breath may provide clues to detect blood cancer, according to new research by scientists at Barts Cancer Institute. The findings could enable the development of a blood cancer...

📰Could a breath test detect blood cancer? New research from @richeslab.bsky.social ‬funded by @bartscharity.bsky.social suggests molecules exhaled in the breath might enable development of a simple, low-cost test to diagnose lymphoma.

@qmul.bsky.social @qmulfmd.bsky.social #medsky #oncosky 🧪

Prof Claude Chelala and her team's research into the inequalities facing women with breast cancer from different ancestries is now featured on @natcomms.nature.com homepage!

Learn more & watch our interview with Prof Chelala: www.bci.qmul.ac.uk/general-news...

#medsky 🧪 #oncosky @qmul.bsky.social

🎉We recently celebrated the inaugural lecture of Professor Andrejs Braun, joined by his family, friends & colleagues.

In his talk, "The Philosopher’s Classroom: Alchemical Fusion of Research and Education," Professor Braun explored the inseparable nature of research & teaching.

@qmul.bsky.social

It's time for STARS! We're opening our doors to the cancer researchers of the future. Over 50 students from schools with historically low uni admissions will get hands-on lab experience at @qmbci.bsky.social, @uclmedsci.bsky.social and @kingslsm.bsky.social.

Find out more: colcc.ac.uk/stars-2025/